It’s no longer a question if these companies will grow; it’s about how and where they choose to grow to offer flexibility, manage risk and support long-term stability.
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Austin's life sciences sector is undergoing rapid ...
Delaware has seen a 65% increase in new biotechnology companies over the past decade, according to a recent report by the Delaware BioScience Association and the Delaware Prosperity Partnership. This ...
Life science campuses of yesteryear' tended to be remote, all-work-no-play settings Today's versions are city-centered and ...
Generative AI-driven analytics platform brings together owned and public data with Oracle Health Real-World Data's millions of de-identified longitudinal EHR records Delivers powerful, deep insights ...
Alisha Hines graduated from an eight-week program in biomanufacturing and life sciences earning what's known as a "microcredential." (Jesse Costa/WBUR) On a recent afternoon at Northeastern University ...
Experts from Dechert, BlueRock Therapeutics, Merck, Seaport Therapeutics, and Ventus Therapeutics examine the impact of recent court rulings following Amgen v. Sanofi on broad genus claims within life ...